We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biopharma Credit Plc | LSE:BPCR | London | Ordinary Share | GB00BDGKMY29 | ORD USD0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.002 | -0.23% | 0.878 | 0.878 | 0.88 | 0.882 | 0.878 | 0.882 | 2,145,874 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 135.74M | 108.45M | 0.0833 | 8.50 | 922.3M |
TIDMBPCR
RNS Number : 8411B
BioPharma Credit PLC
06 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ----------------------------------------------- 1. Identity of the issuer or BioPharma Credit PLC the underlying issuer of existing shares to which voting rights are attached: ---------------------------------------------------------- ------------------------------- 2. Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ------------------------------------------------------------------------------------- ---- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------------------------- ---- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------------------------- ---- An event changing the breakdown of voting rights ------------------------------------------------------------------------------------- ---- Other (please Issue of New Shares Yes specify): --------------------------------------------------------- -------------------------- ---- 3. Full name of person(s) Pablo Legorreta subject to the notification obligation: ---------------------------------------------------------- ------------------------------- 4. Full name of shareholder(s) Pablo Legorreta (if different from 3.): Benjamin Schliemann ---------------------------------------------------------- ------------------------------- 5. Date of the transaction 27 March 2017, 30 March 2017 and date on which the threshold is crossed or reached: ---------------------------------------------------------- ------------------------------- 6. Date on which issuer 5 April 2017 notified: ---------------------------------------------------------- ------------------------------- 7. Threshold(s) that is/are crossed or reached: 3% ---------------------------------------------------------- ------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights ------------- --------------- --------------- -------------- -------------------------- ------------------------- Direct Direct Indirect Direct Indirect / Indirect ------------- ----------- ----------- -------------- ------------- ----------- ------------ ----------- Below Below ORD USD0.01 4% 4% 28,767,015 27,411,842 1,355,173 3.6% 0.2% --------------- --------------- -------------- ------------- ----------- ------------ ----------- GB00BDGKMY29 ------------- ----------- ----------- ------------ ----------- ----------- -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument Period may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------- ---------------------------- --------------------- N/A N/A N/A N/A N/A ----------------- ------------- ------------------------------- ---------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights instrument period refers to --------------- ------------- ------------- ---------------- ---------------------------- ----------------------- N/A N/A N/A N/A N/A Nominal Delta --------------- ------------- ------------- ---------------- ---------------------------- ------------ --------- N/A N/A ------------- ----------- ----------- ------------ ----------- ----------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 28,767,015 3.8% ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------- Proxy Voting: ------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ---------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ---------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ---------------- 13. Additional information: ------------------------------------------------------------- ---------------- 14. Contact name: George Lloyd ------------------------------------------------------------- ---------------- 15. Contact telephone number: +1-212-883-2275 ------------------------------------------------------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNRSRBWASRAR
(END) Dow Jones Newswires
April 06, 2017 10:45 ET (14:45 GMT)
1 Year Biopharma Credit Chart |
1 Month Biopharma Credit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions